• Why is this
    education important?

  • How does this
    hub support you?

  • What can I expect
    when scheduling my program?

  • FAQs

AGA SHORT BOWEL SYNDROME (SBS) SCHEDULING PORTAL

Short Bowel Syndrome Training System

Schedule Your Program

Why is this education important?

This hub provides 3 pathways to meet your needs:

1

Clinicians may lack knowledge about optimal, evidence-based management strategies and treatments for patients with SBS

2

Clinicians may lack knowledge about the best approaches to achieving the long-term goal of enteral autonomy in patients with SBS

3

Multidisciplinary care has clear benefits for patients with SBS, but this approach is not consistently implemented in practice

Ensuring that all clinicians have the knowledge needed to assist patients in progressing toward enteral autonomy and improved quality of life is a critical component of education about SBS. Comprehensive knowledge of strategies is paramount to success.

How does this hub support you?

The AGA Institute and ACHL partnered on this initiative to support your efforts to improve your team’s knowledge of management strategies for pediatric and adult patients with SBS. You can access expert faculty and deliver high-level education efficiently and cost-effectively.

Educators are trained to deliver targeted education considerate of diverse skills and practice settings while applying adult learning principles to foster engagement, promote critical thinking, and acquire enhanced clinical competency. Your team receives access to the latest data and critical real-world perspective and guidance for translating the data to practice.

Learners will improve their ability to apply precision medicine approaches to patients with SBS, in both the pediatric and adult care settings.

What can I expect when scheduling my program?

Access our directory to share your contact details, date and time preferences, topics and length, and number of attendees. You’ll have the opportunity to select up to 3 preferred educators, each of whom is prepared to develop an educational program customized to meet the needs of your team and the diverse patients you treat.

Schedule Your Program Program Scheduling Guide

FAQs

This content is relevant for clinical staff treating pediatric and/or adult patients with SBS, whether in a hospital, clinic, fellowship program, regional society, or other organizations. Our speakers customize the content to your practice mix and setting.

Yes! Return to the AGA Hub and proceed to the 1st pathway to ‘become a speaker.’

The goals of ToT programs are to create consistency, efficiency, and sustainability to improve educational effectiveness. Speakers receive training on adult learning principles, facilitative skills, critical thinking, and strategic assessment of learner/practice setting needs. They begin with a pre-assessment to fully elucidate strengths and areas of development and receive a targeted training program intended to promote mastery of the content. Once individualized needs are identified, a core curriculum developed by experts in the field further improves their knowledge.

Yes, this content library was developed with these objectives:
  • Outline dietary and drug treatment strategies for achieving and maintaining enteral autonomy and promoting intestinal absorption in diverse patients with SBS
  • Describe challenges and unmet needs with parenteral nutrition and identify strategies to reduce patient dependency on parenteral support
  • Implement system-based tools and best practices for providing coordinated, multidisciplinary care for patients with SBS
  • Implement communication and shared decision-making strategies for patients and their caregivers to achieve enteral autonomy
  • Develop individualized, state-of-the-art SBS care plans for diverse groups of patients
AGA Logo ACHL Logo

Sponsored by the American Gastroenterological Association (AGA) Institute and the Academy for Continued Healthcare Learning.

4930 Del Ray Avenue, Bethesda, MD 20814

301-654-2055

  • Connect with AGA

Supported by an unrestricted educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Privacy Policy
© 2025 American Gastroenterological Association
×